Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

Cocaine relapse and health-related quality of life: a 23 weeks study.

Roncero C, Palma-Álvarez RF, Díaz-Morán S, Grau-López L, Rodríguez-Cintas L, Ros-Cucurull E, Álvarez AI, Casas M, Daigre C.

Actas Esp Psiquiatr. 2019 Mar;47(2):37-44. Epub 2019 Mar 1.

2.

The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial.

Barrio P, Roncero C, Ortega L, Guardia J, Yuguero L, Gual A.

J Clin Med. 2019 Apr 6;8(4). pii: E471. doi: 10.3390/jcm8040471.

3.

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin.

Aguilar L, Lorenzo C, Fernández-Ovejero R, Roncero C, Montejo AL.

Front Pharmacol. 2019 Mar 20;10:281. doi: 10.3389/fphar.2019.00281. eCollection 2019. Review.

4.

Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study.

Palma-Álvarez RF, Ros-Cucurull E, Ramos-Quiroga JA, Roncero C, Grau-López L.

Psychopharmacol Bull. 2019 Feb 15;49(1):92-97.

PMID:
30858643
5.

ADGRL3 (LPHN3) variants predict substance use disorder.

Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG; MTA Cooperative Group, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M.

Transl Psychiatry. 2019 Jan 29;9(1):42. doi: 10.1038/s41398-019-0396-7.

6.

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.

Roncero C, Ryan P, Littlewood R, Macías J, Ruiz J, Seijo P, Palma-Álvarez RF, Vega P.

Hepat Med. 2018 Dec 24;11:1-11. doi: 10.2147/HMER.S187133. eCollection 2019.

7.

Benzodiazepine Use Disorder and Cognitive Impairment in Older Patients: A Six-Month-Follow-Up Study in an Outpatient Unit in Barcelona.

Ros-Cucurull E, Palma-Álvarez RF, García-Raboso E, Cardona-Rubira C, Jacas C, Grau-López L, Robles-Martínez M, Daigre C, Ros-Montalbán S, Casas M, Ramos-Quiroga JA, Roncero C.

J Stud Alcohol Drugs. 2018 Nov;79(6):844-852.

PMID:
30573014
8.

Sex differences in an old adult sample with substance use disorder: A 6 months follow-up study.

Ros-Cucurull E, Palma-Álvarez RF, Daigre C, Jacas C, Perea M, Sorribes-Puertas M, Quesada M, Martínez-Arias R, Ros-Montalbán S, Casas M, Ramos-Quiroga JA, Roncero C, Grau-López L.

Psychiatry Res. 2018 Dec;270:1157-1165. doi: 10.1016/j.psychres.2018.10.041. Epub 2018 Oct 16.

PMID:
30551310
9.

Cannabis consumption and psychosis or schizophrenia development.

Ortiz-Medina MB, Perea M, Torales J, Ventriglio A, Vitrani G, Aguilar L, Roncero C.

Int J Soc Psychiatry. 2018 Nov;64(7):690-704. doi: 10.1177/0020764018801690. Review.

PMID:
30442059
10.

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users.

Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L.

Enferm Infecc Microbiol Clin. 2018 Nov 8. pii: S0213-005X(18)30266-0. doi: 10.1016/j.eimc.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30415884
11.

The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs.

Roncero C, Villegas JL, Martínez-Rebollar M, Buti M.

Expert Rev Clin Pharmacol. 2018 Oct;11(10):999-1030. doi: 10.1080/17512433.2018.1519392. Epub 2018 Sep 29. Review.

PMID:
30199279
12.

A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?

Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Adicciones. 2018 Jul 13;0(0):1046. doi: 10.20882/adicciones.1046. [Epub ahead of print] English, Spanish.

13.

Larger Gray Matter Volume in the Basal Ganglia of Heavy Cannabis Users Detected by Voxel-Based Morphometry and Subcortical Volumetric Analysis.

Moreno-Alcázar A, Gonzalvo B, Canales-Rodríguez EJ, Blanco L, Bachiller D, Romaguera A, Monté-Rubio GC, Roncero C, McKenna PJ, Pomarol-Clotet E.

Front Psychiatry. 2018 May 3;9:175. doi: 10.3389/fpsyt.2018.00175. eCollection 2018.

14.

Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample.

Pineda-Cirera L, Cabana-Domínguez J, Roncero C, Cozar M, Grau-López L, Abad AC, Martínez-Luna N, Robles-Martínez M, Sánchez-Mora C, Ramos-Quiroga JA, Casas M, Ribasés M, Fernàndez-Castillo N, Cormand B.

Drug Alcohol Depend. 2018 Jun 1;187:358-362. doi: 10.1016/j.drugalcdep.2018.03.013. Epub 2018 Apr 16.

PMID:
29715653
15.

Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.

Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C; DEPREPOC study investigators.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 6;13:823-831. doi: 10.2147/COPD.S154791. eCollection 2018.

16.

Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Clin Drug Investig. 2018 Apr;38(4):387-388. doi: 10.1007/s40261-018-0625-5. No abstract available.

PMID:
29480453
17.

Latent Impulsivity Subtypes in Substance Use Disorders and Interactions with Internalizing and Externalizing Co-Occurring Disorders.

Marín-Navarrete R, Toledo-Fernández A, Villalobos-Gallegos L, Roncero C, Szerman N, Medina-Mora ME.

Front Psychiatry. 2018 Feb 9;9:27. doi: 10.3389/fpsyt.2018.00027. eCollection 2018.

18.

Anxiety and Depression in Drug-Dependent Patients with Cluster C Personality Disorders.

Roncero C, de Miguel A, Fumero A, Abad AC, Martín R, Bethencourt JM, Grau-López L, Rodríguez-Cintas L, Daigre C.

Front Psychiatry. 2018 Feb 8;9:19. doi: 10.3389/fpsyt.2018.00019. eCollection 2018.

19.

Alcohol use disorder and cognitive impairment in old age patients: A 6 months follow-up study in an outpatient unit in Barcelona.

Ros-Cucurull E, Palma-Álvarez RF, Cardona-Rubira C, García-Raboso E, Jacas C, Grau-López L, Abad AC, Rodríguez-Cintas L, Ros-Montalbán S, Casas M, Ramos-Quiroga JA, Roncero C.

Psychiatry Res. 2018 Mar;261:361-366. doi: 10.1016/j.psychres.2017.12.069. Epub 2018 Jan 4.

PMID:
29353762
20.

Harm reduction program use, psychopathology and medical severity in patients with methadone maintenance treatment.

Martínez-Luna NG, Rodríguez-Cintas L, Esojo A, Palma-Álvarez RF, Robles-Martínez M, Grau-López L, Perea M, Roncero C.

Adicciones. 2018 Jan 15;30(3):197-207. doi: 10.20882/adicciones.897. English, Spanish.

Supplemental Content

Loading ...
Support Center